Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-038199
Filing Date
2013-07-02
Accepted
2013-07-02 17:56:20
Documents
1
Period of Report
2013-06-28

Document Format Files

Seq Description Document Type Size
1 10B5-1 PLAN EXERCISE AND SALE rrd384828.html 4  
1 10B5-1 PLAN EXERCISE AND SALE rrd384828.xml 4 7580
  Complete submission text file 0001181431-13-038199.txt   9168
Mailing Address C/O BIOENVISION, INC. 345 PARK AVENUE, 41ST. FLOOR NEW YORK NY 10154
Business Address
Scibetta James S (Reporting) CIK: 0001383242 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 13950199

Mailing Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 100 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations